title: [Highly-resistant Streptococcus pneumoniae meningitis in Central America].
authors.forename: R
authors.initials: R
authors.lastname: Ulloa-Gutiérrez
authors.forename: M L
authors.initials: ML
authors.lastname: Avila-Agüero
authors.forename: M L
authors.initials: ML
authors.lastname: Herrera
authors.forename: J F
authors.initials: JF
authors.lastname: Herrera
authors.forename: A
authors.initials: A
authors.lastname: Vargas
authors.forename: T
authors.initials: T
authors.lastname: Barton
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use*; D002489:Central America / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008297:Male; D008586:Meningitis, Pneumococcal / Q000188:drug therapy / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D014640:Vancomycin / Q000627:therapeutic use; D018440:beta-Lactam Resistance
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002439:Cefotaxime